LABORATORY INVESTIGATION REPORT
Patient Name : Mr. PRASHANT BAGHEL Age/Sex : 23Year(s) / Male
UHID : AIGG.20963947 Order Date : 09-04-2025 13:35
Episode : OP
Ref. Doctor : Dr.SUNDEEP LAKHTAKIA Mobile No : 8193884807
Facility : AIG Hospitals, Gachibowli
Biochemistry
TEST RESULT UNIT BIOLOGICAL REF INTERVAL
Sample No : AGH1018024B Collection Date : 09/04/25 13:44 Ack Date : 09/04/2025 14:51 Report Date : 09/04/25 15:16
HBA1C
Sample- EDTA Whole Blood
HBA1C VALUE 5.1 % <5.7
Method - BORONATE AFFINITY HPLC
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ __ _ _ _ __ _ _ _ __ _ __ _ _ _ __ _ __ _
| As per American Diabetes Association (ADA) |
| _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ __ _ _ _ __ _ _ _ __ _ __ _ _ _ ___ __ _ |
| Reference Group | HbA1c in % |
|_ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __|
| Non diabetic adults | >=18 years <5.7 |
|_ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ |
| At risk (Prediabetes) | 5.7 - 6.4 |
|_ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ |
| Diagnosing Diabetes | >= 6.5 |
|_ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ |
| Therapeutic goals for glycemic control | > 19 years |
| | Goal of therapy: < 7.0 |
| | Action suggested: >8.0 |
| | Age<19 Years |
| | Goal of therapy: < 7.5 |
_ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ _ _ _ __ _ _ _ |_ _ _ _ _ _ _ _ _ _ _ _ _ ___ |
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may
still have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant
cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions,
targeting a goal of < 7.0 % may not be appropriate.
Comments: HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term
glycemic control as compared to blood and urinary glucose determinations.
Cautions: In cases of hemolytic anemia. the lifetime of erythrocytes is shortened and will result in decreased HBA1c results. This effect will
depend upon the severity of the anemia.
• Falsely low HbA1c results less than 4.0% may be observed in patients with shorten erythrocyte life span or decrease mean erythrocyte
age. Specimens from patients with polycythemia or post-splenectomy may exhibit increased HBA1c values due to a somewhat longer
lifespan of the erythrocytes.
• The presence of hemoglobin variants In patients with rare homozygous and double heterozygous forms of abnormal Hb (eg, CC, SS, EE,
SC), there is no HbA present; therefore can interfere with the measurement of hemoglobin A1c (HbA1c). Fructosamine may be used as an
alternate measurement to monitor glycemic control.
Page 1 of 2
LABORATORY INVESTIGATION REPORT
Patient Name : Mr. PRASHANT BAGHEL Age/Sex : 23Year(s) / Male
UHID : AIGG.20963947 Order Date : 09-04-2025 13:35
Episode : OP
Ref. Doctor : Dr.SUNDEEP LAKHTAKIA Mobile No : 8193884807
Facility : AIG Hospitals, Gachibowli
Report Saved By - NAMBURU VEERAIAH (09/04/2025 15:49 PM)
End of Report
Dr.G. DEEPIKA
MD Biochemistry, Sr.Consultant
HOD Biochemistry
Page 2 of 2
